Ideaya Biosciences (IDYA) announced the initiation of a Phase 1/2 expansion in the clinical trial evaluating IDE397, its investigational, small molecule methionine adenosyltransferase 2a inhibitor ...

Renovaro Biosciences (RENB) closed its previously announced merger transaction with BioSymetrics on April 8. Renovaro’s merger with BioSymetrics is designed to enhance Renovaro’s data ...

On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years ...

Or it was – until now. The US company Colossal Biosciences claims to have revived the animal. The company from Austin in the US state of Texas calls itself “the world's only de-extinction ...

Besides reviving the extinct dire wolf, Dallas' Colossal Biosciences is also working to bolster the critically endangered Eastern red wolf population.

KBI Global Investors Aquarius Fund earns an Average Process Pillar rating. The main contributor to the rating is the fund's strong long-term risk-adjusted performance. This can be seen in its five ...

The BD Accuri™ C6 is a personal flow cytometer that brings flow cytometry within reach by being easy to use, simple to maintain, and affordable. The analytical power and versatility of today’s ...

At close: April 11 at 4:00:01 PM EDT ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.